| | | | | | | | | | |
|
|
| Dockets Entered
On November 10, 2004
Table of Contents
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 1986V-0090
|
| SPECTRASCAN PROJECTOR WITH HS-100 SCANNING CONTROL SYSTEM
|
|
|
| 1988N-0004
|
| Pediatric dosing information for OTC; request for informatio
|
|
|
| 1993V-0133
|
| Laser Light Show
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
| 1998P-0151
|
| Introduction Of Downed Cattle Into The Food Supply
|
|
|
| 1999P-1340
|
| Declared Eternity eau de Parfum Misbranded
|
|
|
| 1999P-2630
|
| Establish a Daily Value for "added sugars"
|
|
|
| 1999P-5106
|
| Identify Sources of Natural Flavorings
|
|
|
| 2001P-0075
|
| Switch Status of Emergency Contraceptives from Rx to OTC
|
|
|
| 2001P-0345
|
| Listing the color additive yellow #5 for use in food/Drug
|
|
|
| 2002D-0325
|
| Polyvinychloride using Plasticier di-(2-ethyhexyl)phthalate
|
|
|
| 2003D-0554
|
| Compliance Policy Guide Sec. 110.310 Prior Notice of Imported Food Under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002
|
|
|
| 2003D-0562
|
| Compliance Policy Guide Sec.110.300 Registration of Food Facilities Under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
|
| 2003N-0169
|
| Dental Amalgam; Request for Information
|
|
|
| 2003N-0481
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Food Additive Petitions
|
|
|
| 2003V-0293
|
| Laser Light Show
|
|
|
| 2003V-0306
|
| Laser Light Show
|
|
|
| 2004D-0465
|
| Guidance for FDA Review Staff and Sponsors: Content and Review of Chemistry, Manufacturing, and Control (CMC) Information for Human Gene Therapy Investigational New Drug Applications (INDs)
|
|
|
|
| 2004D-0466
|
| Guidance for Industry: Substantiation for Dietary Supplement Claims Made Under Section 403(r) (6) of the Federal Food, Drug, and Cosmetic Act
|
|
|
| 2004D-0468
|
| Draft Guidance for Industry on Development of Target Animal Safety and Effectiveness Data to Support Approval of Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) for use in Animals
|
|
|
| 2004N-0244
|
| Agency Information Collection Activities: Proposed Collection; Comment Request;
|
|
|
| 2004N-0332
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Medical Devices; Third Party Review under FDAMA
|
|
|
| 2004N-0428
|
| Preparation for the International Conference on Harmonization Meetings in Yokohama, Japan: Public Meeting
|
|
|
| 2004N-0454
|
| Dietary Supplements; Premarket Notification for New Dietary Ingredient Notifications; Public Meeting
|
|
|
| 2004N-0458
|
| Dietary Supplements; Regulatory Strategy for the Further Implementation and Enforcement of the Dietary Supplement Health and Education Act of 1994
|
|
|
| 2004N-0470
|
| Agency Information Collection Activities: Proposed Collection; Comment Request;
|
|
|
| 2004N-0480
|
| The Minor Use & Minor Species (MUMS) Animal Health Act
|
|
|
| 2004N-0502
|
| Animal Models and Correlates of Protection for Plague Vaccines, Public Workshop
|
|
|
| 2004P-0059
|
| Health Claim Petition: Glucosamine and Chondroitin Sulfate and Osteoarthritis
|
|
|
| 2004P-0489
|
| ANADA Suitability Petition for generic serum gonadotropin and chorionic gonadotropin for injection
|
|
|
| 2004P-0500
|
| Meperidine Hydrochloirde Tablets in two strengths of 75 mg and 150 mg suitable for ANDA
|
|
|
| 2004Q-0144
|
| Qualified Health Claim (QHC): Chromium picolinate and Diabetes
|
|
|
| 1986V-0090
|
| SPECTRASCAN PROJECTOR WITH HS-100 SCANNING CONTROL SYSTEM
|
|
|
| VRA
7
|
| HFZ-300 to Holo Spectra, Inc.
|
| Vol #:
|
| 1
|
|
| | | | | | | | |
|
|
| 1988N-0004
|
| Pediatric dosing information for OTC; request for informatio
|
|
|
| BKG 1
|
| Background Material
|
| Vol #:
|
| 1
|
|
|
| 1993V-0133
|
| Laser Light Show
|
|
|
| VRA
6
|
| HFZ-300 to Flandrau Science Center & Planetarium
|
| Vol #:
|
| 1
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
| LET
14729
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 129
|
|
|
| LET
14730
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 129
|
|
|
| LET
14731
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 129
|
|
|
| LET
14732
|
| Ashbury Biologicals Inc.
|
| Vol #:
|
| 129
|
|
|
| LET
14733
|
| Ashbury Biologicals Inc.
|
| Vol #:
|
| 129
|
|
|
| LET
14734
|
| Ajinomoto U.S.A., Inc.
|
| Vol #:
|
| 129
|
|
|
| LET
14735
|
| Advocare International, L.P.
|
| Vol #:
|
| 129
|
|
|
| LET
14736
|
| Fitness Labs Nutrition Corporation
|
| Vol #:
|
| 129
|
|
|
| LET
14737
|
| Fitness Labs Nutrition Corporation
|
| Vol #:
|
| 129
|
|
|
| LET
14738
|
| Fitness Labs Nutritiion Corporation
|
| Vol #:
|
| 129
|
|
|
| LET
14739
|
| Fitness Labs Nutrition Corporation
|
| Vol #:
|
| 129
|
|
|
| 1998P-0151
|
| Introduction Of Downed Cattle Into The Food Supply
|
|
|
| EMC 4288
|
| P. Pannucci
|
| Vol #:
|
| 320
|
|
|
| EMC 4289
|
| P. Pannucci
|
| Vol #:
|
| 320
|
|
|
| EMC 4290
|
| A. Mithoff
|
| Vol #:
|
| 320
|
|
|
| 1999P-1340
|
| Declared Eternity eau de Parfum Misbranded
|
|
|
| EMC 559
|
| D. Steinberg
|
| Vol #:
|
| 24
|
|
|
| 1999P-2630
|
| Establish a Daily Value for "added sugars"
|
|
|
| C 617
|
| S. Brown
|
| Vol #:
|
| 33
|
|
|
| 1999P-5106
|
| Identify Sources of Natural Flavorings
|
|
|
| SUP 1
|
| R. Claypool
|
| Vol #:
|
| 3
|
|
|
| 2001P-0075
|
| Switch Status of Emergency Contraceptives from Rx to OTC
|
|
|
| EMC 10987
|
| N. Lai
|
| Vol #:
|
| 296
|
|
|
| EMC 10988
|
| B. Dore
|
| Vol #:
|
| 286
|
|
|
| EMC 10989
|
| E. Chang
|
| Vol #:
|
| 296
|
|
|
| EMC 10990
|
| S. Adams
|
| Vol #:
|
| 296
|
|
|
| EMC 10991
|
| F. Frenkel
|
| Vol #:
|
| 296
|
|
| | | | | | | | |
|
|
| EMC 11066
|
| S. Draper
|
| Vol #:
|
| 296
|
|
|
| EMC 11067
|
| L. Brown
|
| Vol #:
|
| 296
|
|
|
| EMC 11068
|
| A. Alexy
|
| Vol #:
|
| 296
|
|
|
| EMC 11069
|
| B. Clapper
|
| Vol #:
|
| 296
|
|
|
| EMC 11070
|
| S. Trieu
|
| Vol #:
|
| 296
|
|
|
| EMC 11071
|
| B. Peterson
|
| Vol #:
|
| 296
|
|
|
| 2001P-0345
|
| Listing the color additive yellow #5 for use in food/Drug
|
|
|
| EMC 1250
|
| D. Jong
|
| Vol #:
|
| 5
|
|
|
| 2002D-0325
|
| Polyvinychloride using Plasticier di-(2-ethyhexyl)phthalate
|
|
|
| EMC 195
|
| B. Hickey
|
| Vol #:
|
| 3
|
|
|
| EMC 196
|
| B. Hickey
|
| Vol #:
|
| 3
|
|
|
| 2003D-0554
|
| Compliance Policy Guide Sec. 110.310 Prior Notice of Imported Food Under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002
|
|
|
| GDL
4
|
| Guidance
|
| Vol #:
|
| 1
|
|
|
| NAD
4
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2003D-0562
|
| Compliance Policy Guide Sec.110.300 Registration of Food Facilities Under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002
|
|
|
| GDL
2
|
| Guidance
|
| Vol #:
|
| 1
|
|
|
| NAD
2
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
|
| EMC 450
|
| No signature
|
| Vol #:
|
| 9
|
|
|
| EMC 451
|
| J. Stevens
|
| Vol #:
|
| 9
|
|
|
| EMC 452
|
| C. Zvolanek
|
| Vol #:
|
| 9
|
|
|
| EMC 453
|
| J. Cline
|
| Vol #:
|
| 9
|
|
|
| EMC 454
|
| B. Pinkham, Jr.
|
| Vol #:
|
| 9
|
|
|
| EMC 455
|
| M. Twyford
|
| Vol #:
|
| 9
|
|
|
| EMC 456
|
| R. Bradsher
|
| Vol #:
|
| 9
|
|
|
| 2003N-0169
|
| Dental Amalgam; Request for Information
|
|
|
| EMC
276
|
| Consumers for Dental Choice
|
| Vol #:
|
| 6
|
|
|
| EMC
277
|
| Consumers for Dental Choice
|
| Vol #:
|
| 6
|
|
|
| 2003N-0481
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Food Additive Petitions
|
|
|
| NAL
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| SS
1
|
| Supporting Statement
|
| Vol #:
|
| 1
|
|
|
| 2003V-0293
|
| Laser Light Show
|
|
| | | | | | | | |
|
|
| VRA
2
|
| HFZ-300 to LumaLaser
|
| Vol #:
|
| 1
|
|
|
| 2003V-0306
|
| Laser Light Show
|
|
|
| VRA
1
|
| HFZ-300 to Visiotopic System LLC
|
| Vol #:
|
| 1
|
|
|
| 2004D-0465
|
| Guidance for FDA Review Staff and Sponsors: Content and Review of Chemistry, Manufacturing, and Control (CMC) Information for Human Gene Therapy Investigational New Drug Applications (INDs)
|
|
|
|
|
|
|
| GDL
1
|
| Guidance
|
| Vol #:
|
| 1
|
|
|
| NAD
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2004D-0466
|
| Guidance for Industry: Substantiation for Dietary Supplement Claims Made Under Section 403(r) (6) of the Federal Food, Drug, and Cosmetic Act
|
|
|
| GDL
1
|
| Guidance
|
| Vol #:
|
| 1
|
|
|
| NAD
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2004D-0468
|
| Draft Guidance for Industry on Development of Target Animal Safety and Effectiveness Data to Support Approval of Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) for use in Animals
|
|
|
|
|
|
|
| GDL
1
|
| Guideline
|
| Vol #:
|
| 1
|
|
|
| NAD
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2004N-0244
|
| Agency Information Collection Activities: Proposed Collection; Comment Request;
|
|
|
| N
2
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2004N-0332
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Medical Devices; Third Party Review under FDAMA
|
|
|
| N
2
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2004N-0428
|
| Preparation for the International Conference on Harmonization Meetings in Yokohama, Japan: Public Meeting
|
|
|
| NM
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| TR
1
|
| Transcript of October 19, 2004 Public Meeting
|
| Vol #:
|
| 1
|
|
|
| 2004N-0454
|
| Dietary Supplements; Premarket Notification for New Dietary Ingredient Notifications; Public Meeting
|
|
|
| EMC 3
|
| T. Singeltary Sr.
|
| Vol #:
|
| 1
|
|
|
| EMC 4
|
| T. Singeltary Sr.
|
| Vol #:
|
| 1
|
|
|
| 2004N-0458
|
| Dietary Supplements; Regulatory Strategy for the Further Implementation and Enforcement of the Dietary Supplement Health and Education Act of 1994
|
|
|
| BKG
1
|
| Implementation Strategy
|
| Vol #:
|
| 1
|
|
|
| NAD
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2004N-0470
|
| Agency Information Collection Activities: Proposed Collection; Comment Request;
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2004N-0480
|
| The Minor Use & Minor Species (MUMS) Animal Health Act
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
| | | | | | | | |
|
|
| 2004N-0502
|
| Animal Models and Correlates of Protection for Plague Vaccines, Public Workshop
|
|
|
| NM
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| TR
1
Part 2, part
3
|
| Transcript of October 13, 2004 Workshop
|
| Vol #:
|
| 1
|
|
|
| TR
2
Part 2
|
| Transcript of October 14, 2004 Workshop
|
| Vol #:
|
| 2
|
|
|
| 2004P-0059
|
| Health Claim Petition: Glucosamine and Chondroitin Sulfate and Osteoarthritis
|
|
|
| EMC
2
|
| Weider Nutrition International, Inc.
|
| Vol #:
|
| 13
|
|
|
| 2004P-0489
|
| ANADA Suitability Petition for generic serum gonadotropin and chorionic gonadotropin for injection
|
|
|
| WDL
1
|
| Bioniche Animal Health USA, Inc.
|
| Vol #:
|
| 1
|
|
|
| 2004P-0500
|
| Meperidine Hydrochloirde Tablets in two strengths of 75 mg and 150 mg suitable for ANDA
|
|
|
| ACK
1
|
| Lachman Consultant Services, Inc.
|
| Vol #:
|
| 1
|
|
|
| CP
1
Attachment A,
B, C
|
| Lachman Consultant Services, Inc.
|
| Vol #:
|
| 1
|
|
|
| 2004Q-0144
|
| Qualified Health Claim (QHC): Chromium picolinate and Diabetes
|
|
|
| EMC
2
|
| Emord & Associates, P.C.
|
| Vol #:
|
| 11
|
|